{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:34:36Z","timestamp":1791203676689,"version":"4.2.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,13]],"date-time":"2013-01-13T00:00:00Z","timestamp":1358035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12020-012-9871-0","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T04:23:55Z","timestamp":1357964635000},"page":"220-227","source":"Crossref","is-referenced-by-count":6,"title":["Different levels of various glucocorticoid-regulated genes in corticotroph adenomas"],"prefix":"10.1007","volume":"44","author":[{"given":"Johan Arild","family":"Evang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Casar-Borota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Lekva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Ramm-Pettersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Petter","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,13]]},"reference":[{"key":"9871_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12020-009-9163-5","volume":"35","author":"V Hook","year":"2009","unstructured":"V. Hook, L. Funkelstein, T. Toneff, C. Mosier, S.R. Hwang, Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin. Endocrine 35, 429\u2013437 (2009)","journal-title":"Endocrine"},{"key":"9871_CR2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jc.83.3.917","volume":"83","author":"NA Huizenga","year":"1998","unstructured":"N.A. Huizenga, P. de Lange, J.W. Koper, R.N. Clayton, W.E. Farrell, A.J. van der Lely, A.O. Brinkmann, F.H. de Jong, S.W. Lamberts, Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. J. Clin. Endocrinol. Metab. 83, 917\u2013921 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR4","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.86.6.2728","volume":"86","author":"M Korbonits","year":"2001","unstructured":"M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A.B. Grossman, P.M. Stewart, Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J. Clin. Endocrinol. Metab. 86, 2728\u20132733 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR5","first-page":"296","volume":"108","author":"M Karl","year":"1996","unstructured":"M. Karl, S.W. Lamberts, J.W. Koper, D.A. Katz, N.E. Huizenga, T. Kino, B.R. Haddad, M.R. Hughes, G.P. Chrousos, Cushing\u2019s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc. Assoc. Am. Physicians 108, 296\u2013307 (1996)","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"9871_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-2265.2002.01639.x","volume":"57","author":"SR Antonini","year":"2002","unstructured":"S.R. Antonini, A.C. Latronico, L.L. Elias, A. Cukiert, H.R. Machado, B. Liberman, B.B. Mendonca, A.C. Moreira, M. Castro, Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours. Clin. Endocrinol. (Oxf.) 57, 657\u2013662 (2002)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9871_CR7","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1210\/jc.2002-022048","volume":"88","author":"DG Morris","year":"2003","unstructured":"D.G. Morris, B. Kola, N. Borboli, G.A. Kaltsas, M. Gueorguiev, A.M. McNicol, R. Ferrier, T.H. Jones, S. Baldeweg, M. Powell, S. Czirjak, Z. Hanzely, J.O. Johansson, M. Korbonits, A.B. Grossman, Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 88, 6080\u20136087 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/153537020322800904","volume":"228","author":"A Lania","year":"2003","unstructured":"A. Lania, G. Mantovani, A. Spada, Genetics of pituitary tumors: focus on G-protein mutations. Exp. Biol. Med. (Maywood) 228, 1004\u20131017 (2003)","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"9871_CR9","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1101\/gad.1444606","volume":"20","author":"S Bilodeau","year":"2006","unstructured":"S. Bilodeau, S. Vallette-Kasic, Y. Gauthier, D. Figarella-Branger, T. Brue, F. Berthelet, A. Lacroix, D. Batista, C. Stratakis, J. Hanson, B. Meij, J. Drouin, Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 20, 2871\u20132886 (2006)","journal-title":"Genes Dev."},{"key":"9871_CR10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117943","volume":"95","author":"CM Bamberger","year":"1995","unstructured":"C.M. Bamberger, A.M. Bamberger, M. de Castro, G.P. Chrousos, Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95, 2435\u20132441 (1995)","journal-title":"J. Clin. Invest."},{"key":"9871_CR11","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1007\/s00018-009-0098-z","volume":"66","author":"T Kino","year":"2009","unstructured":"T. Kino, Y.A. Su, G.P. Chrousos, Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell. Mol. Life Sci. 66, 3435\u20133448 (2009)","journal-title":"Cell. Mol. Life Sci."},{"key":"9871_CR12","doi-asserted-by":"crossref","first-page":"ra8","DOI":"10.1126\/scisignal.2000568","volume":"3","author":"T Kino","year":"2010","unstructured":"T. Kino, D.E. Hurt, T. Ichijo, N. Nader, G.P. Chrousos, Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8 (2010)","journal-title":"Sci. Signal."},{"key":"9871_CR13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.84.2.663","volume":"84","author":"PD Reynolds","year":"1999","unstructured":"P.D. Reynolds, Y. Ruan, D.F. Smith, J.G. Scammell, Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J. Clin. Endocrinol. Metab. 84, 663\u2013669 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR14","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1210\/en.2005-0027","volume":"146","author":"WB Denny","year":"2005","unstructured":"W.B. Denny, V. Prapapanich, D.F. Smith, J.G. Scammell, Structure\u2013function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity. Endocrinology 146, 3194\u20133201 (2005)","journal-title":"Endocrinology"},{"key":"9871_CR15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/modpathol.3800965","volume":"20","author":"ZR Qian","year":"2007","unstructured":"Z.R. Qian, T. Sano, K. Yoshimoto, S.L. Asa, S. Yamada, N. Mizusawa, E. Kudo, Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod. Pathol. 20, 1269\u20131277 (2007)","journal-title":"Mod. Pathol."},{"key":"9871_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1227\/01.NEU.0000349930.66434.82","volume":"65","author":"F Salehi","year":"2009","unstructured":"F. Salehi, A. Agur, B.W. Scheithauer, K. Kovacs, R.V. Lloyd, M. Cusimano, Ki-67 in pituitary neoplasms: a review\u2014part I. Neurosurgery 65, 429\u2013437 (2009)","journal-title":"Neurosurgery"},{"key":"9871_CR17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2265.2011.04109.x","volume":"75","author":"JA Evang","year":"2011","unstructured":"J.A. Evang, J.P. Berg, O. Casar-Borota, T. Lekva, M.K. Kringen, J. Ramm-Pettersen, J. Bollerslev, Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours. Clin. Endocrinol. (Oxf.) 75, 811\u2013818 (2011)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9871_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1380153","volume":"138","author":"P Selvais","year":"1998","unstructured":"P. Selvais, J. Donckier, M. Buysschaert, D. Maiter, Cushing\u2019s disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. Eur. J. Endocrinol. 138, 153\u2013159 (1998)","journal-title":"Eur. J. Endocrinol."},{"key":"9871_CR19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/jc.83.5.1619","volume":"83","author":"L Katznelson","year":"1998","unstructured":"L. Katznelson, J.S. Bogan, J.R. Trob, D.A. Schoenfeld, E.T. Hedley-Whyte, D.W. Hsu, N.T. Zervas, B. Swearingen, M. Sleeper, A. Klibanski, Biochemical assessment of Cushing\u2019s disease in patients with corticotroph macroadenomas. J. Clin. Endocrinol. Metab. 83, 1619\u20131623 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR20","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2005-0070","volume":"90","author":"YS Woo","year":"2005","unstructured":"Y.S. Woo, A.M. Isidori, W.Z. Wat, G.A. Kaltsas, F. Afshar, I. Sabin, P.J. Jenkins, J.P. Monson, G.M. Besser, A.B. Grossman, Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J. Clin. Endocrinol. Metab. 90, 4963\u20134969 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9440(10)64725-6","volume":"156","author":"M Losa","year":"2000","unstructured":"M. Losa, R.L. Barzaghi, P. Mortini, A. Franzin, F. Mangili, M.R. Terreni, M. Giovanelli, Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas. Am. J. Pathol. 156, 245\u2013251 (2000)","journal-title":"Am. J. Pathol."},{"key":"9871_CR22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/EJE-10-0466","volume":"163","author":"TM Barber","year":"2010","unstructured":"T.M. Barber, E. Adams, O. Ansorge, J.V. Byrne, N. Karavitaki, J.A. Wass, Nelson\u2019s syndrome. Eur. J. Endocrinol. 163, 495\u2013507 (2010)","journal-title":"Eur. J. Endocrinol."},{"key":"9871_CR23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1074-7613(00)80398-2","volume":"7","author":"F D\u2019Adamio","year":"1997","unstructured":"F. D\u2019Adamio, O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, L. Cannarile, G. Migliorati, C. Riccardi, A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR\/CD3-activated cell death. Immunity 7, 803\u2013812 (1997)","journal-title":"Immunity"},{"key":"9871_CR24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.onc.1209218","volume":"25","author":"Z Wang","year":"2006","unstructured":"Z. Wang, Y.P. Rong, M.H. Malone, M.C. Davis, F. Zhong, C.W. Distelhorst, Thioredoxin-interacting protein (TXNIP) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 25, 1903\u20131913 (2006)","journal-title":"Oncogene"},{"key":"9871_CR25","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood-2006-11-056366","volume":"109","author":"WJ Tissing","year":"2007","unstructured":"W.J. Tissing, M.L. Den Boer, J.P. Meijerink, R.X. Menezes, S. Swagemakers, P.J. van der Spek, S.E. Sallan, S.A. Armstrong, R. Pieters, Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood 109, 3929\u20133935 (2007)","journal-title":"Blood"},{"key":"9871_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jc.2009-0595","volume":"95","author":"T Lekva","year":"2010","unstructured":"T. Lekva, J. Bollerslev, C. Kristo, O.K. Olstad, T. Ueland, R. Jemtland, The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing\u2019s syndrome and may play a role in glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab. 95, 246\u2013255 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"9871_CR27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1530\/EJE-11-1082","volume":"166","author":"T Lekva","year":"2012","unstructured":"T. Lekva, T. Ueland, H. Boyum, J.A. Evang, K. Godang, J. Bollerslev, TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing\u2019s syndrome and related to bone turnover. Eur. J. Endocrinol. 166(6), 1039\u20131048 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"9871_CR28","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1073\/pnas.0801551105","volume":"105","author":"AY So","year":"2008","unstructured":"A.Y. So, S.B. Cooper, B.J. Feldman, M. Manuchehri, K.R. Yamamoto, Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc. Natl. Acad. Sci. USA. 105, 5745\u20135749 (2008)","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"9871_CR29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2007-2272","volume":"93","author":"SL Fougner","year":"2008","unstructured":"S.L. Fougner, J. Bollerslev, F. Latif, J.K. Hald, T. Lund, J. Ramm-Pettersen, J.P. Berg, Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. J. Clin. Endocrinol. Metab. 93, 1211\u20131216 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-10-0076","volume":"163","author":"G Raverot","year":"2010","unstructured":"G. Raverot, A. Wierinckx, E. Jouanneau, C. Auger, F. Borson-Chazot, J. Lachuer, M. Pugeat, J. Trouillas, Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing\u2019s disease. Eur. J. Endocrinol. 163, 35\u201343 (2010)","journal-title":"Eur. J. Endocrinol."},{"key":"9871_CR31","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/sj.leu.2403516","volume":"18","author":"U M","year":"2004","unstructured":"U. M, L. Shen, T. Oshida, J. Miyauchi, M. Yamada, T. Miyashita, Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 18, 1850\u20131856 (2004)","journal-title":"Leukemia"},{"key":"9871_CR32","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2009-2197","volume":"95","author":"SL Fougner","year":"2010","unstructured":"S.L. Fougner, T. Lekva, O.C. Borota, J.K. Hald, J. Bollerslev, J.P. Berg, The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J. Clin. Endocrinol. Metab. 95, 2334\u20132342 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/jc.2008-2075","volume":"94","author":"MS Elston","year":"2009","unstructured":"M.S. Elston, A.J. Gill, J.V. Conaglen, A. Clarkson, R.J. Cook, N.S. Little, B.G. Robinson, R.J. Clifton-Bligh, K.L. McDonald, Nuclear accumulation of E-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. J. Clin. Endocrinol. Metab. 94, 1436\u20131442 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9871_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1385\/EP:13:4:341","volume":"13","author":"B Xu","year":"2002","unstructured":"B. Xu, T. Sano, K. Yoshimoto, S. Yamada, Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocr. Pathol. 13, 341\u2013351 (2002)","journal-title":"Endocr. Pathol."},{"key":"9871_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1005709014239","volume":"34","author":"H Kawamoto","year":"1997","unstructured":"H. Kawamoto, T. Mizoue, K. Arita, A. Tominaga, K. Eguchi, K. Kurisu, Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas. J. Neurooncol. 34, 105\u2013109 (1997)","journal-title":"J. Neurooncol."},{"key":"9871_CR36","first-page":"831","volume":"146","author":"S Wolfsberger","year":"2004","unstructured":"S. Wolfsberger, J. Wunderer, I. Zachenhofer, T. Czech, H.G. Bocher-Schwarz, J. Hainfellner, E. Knosp, Expression of cell proliferation markers in pituitary adenomas\u2014correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Acta Neurochir. 146, 831\u2013839 (2004)","journal-title":"Acta Neurochir."},{"key":"9871_CR37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1054\/bjoc.1999.1074","volume":"82","author":"HE Turner","year":"2000","unstructured":"H.E. Turner, Z. Nagy, K.C. Gatter, M.M. Esiri, J.A. Wass, A.L. Harris, Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br. J. Cancer 82, 1441\u20131445 (2000)","journal-title":"Br. J. Cancer"},{"key":"9871_CR38","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1227\/NEU.0b013e3181faa680","volume":"67","author":"F Salehi","year":"2010","unstructured":"F. Salehi, A. Agur, B.W. Scheithauer, K. Kovacs, R.V. Lloyd, M. Cusimano, Biomarkers of pituitary neoplasms: a review (Part II). Neurosurgery 67, 1790\u20131798 (2010)","journal-title":"Neurosurgery"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9871-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9871-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T03:11:34Z","timestamp":1562555494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,13]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9871"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9871-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,13]]}}}